Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
Severe durable changes may occur to the DNA structure caused by exogenous and
endogenous risk factors initiating the process of carcinogenesis. By evidence, a large …
endogenous risk factors initiating the process of carcinogenesis. By evidence, a large …
[HTML][HTML] Natural products for combating multidrug resistance in cancer
T Chen, Z Xiao, X Liu, T Wang, Y Wang, F Ye… - Pharmacological …, 2024 - Elsevier
Cancer cells frequently develop resistance to chemotherapeutic therapies and targeted
drugs, which has been a significant challenge in cancer management. With the growing …
drugs, which has been a significant challenge in cancer management. With the growing …
Tropolone natural products
H Guo, D Roman, C Beemelmanns - Natural product reports, 2019 - pubs.rsc.org
Covering: 2008 to 2018 This review provides a comprehensive overview of newly
discovered natural products containing a tropolonoid motif covering 2008 up to 2018 and …
discovered natural products containing a tropolonoid motif covering 2008 up to 2018 and …
Natural compounds that target DNA repair pathways and their therapeutic potential to counteract cancer cells
FA Lagunas-Rangel, RM Bermúdez-Cruz - Frontiers in Oncology, 2020 - frontiersin.org
Resistance to current cancer treatments is an important problem that arises through various
mechanisms, but one that stands out involves an overexpression of several factors …
mechanisms, but one that stands out involves an overexpression of several factors …
Design, synthesis and biological evaluation of 2-quinolyl-1, 3-tropolone derivatives as new anti-cancer agents
EA Gusakov, IA Topchu, AM Mazitova, IV Dorogan… - RSC …, 2021 - pubs.rsc.org
Tropolones are promising organic compounds that can have important biologic effects. We
developed a series of new 2-quinolyl-1, 3-tropolones derivatives that were prepared by the …
developed a series of new 2-quinolyl-1, 3-tropolones derivatives that were prepared by the …
Chalcomoracin inhibits cell proliferation and increases sensitivity to radiotherapy in human non-small cell lung cancer cells via inducing endoplasmic reticulum stress …
S Zhang, X Zhang, J Liang, H Fang, H Huang… - Acta Pharmacologica …, 2020 - nature.com
Chalcomoracin (CMR) is a kind of Diels–Alder adduct extracted from the mulberry leaves.
Recent studies showed that CMR has a broad spectrum of anticancer activities and induces …
Recent studies showed that CMR has a broad spectrum of anticancer activities and induces …
The radiosensitizing effect of β-Thujaplicin, a tropolone derivative inducing S-phase cell cycle arrest, in head and neck squamous cell carcinoma-derived cell lines
M Haas, T Lenz, L Kadletz-Wanke… - Investigational New …, 2022 - Springer
Background Resistance to radiotherapy is a common cause of treatment failure in advanced
head and neck squamous cell carcinoma (HNSCC). ß-Thujaplicin, a natural tropolone …
head and neck squamous cell carcinoma (HNSCC). ß-Thujaplicin, a natural tropolone …
Screening a redox library identifies the anti-tumor drug Hinokitiol for treating intrahepatic cholangiocarcinoma
Aims: Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and heterogeneous
cancer with a poor prognosis. At present, there is no optimal treatment except for surgical …
cancer with a poor prognosis. At present, there is no optimal treatment except for surgical …
[HTML][HTML] О механизмах противоопухолевого действия соединений трополонового ряда
ГВ Жукова, ЕА Лукбанова, ТП Протасова… - Research'n Practical …, 2021 - cyberleninka.ru
В обзоре приведены сведения о механизмах противоопухолевого действия природных
и синтетических соединений трополонового ряда, полученные в течение последних 30 …
и синтетических соединений трополонового ряда, полученные в течение последних 30 …
[PDF][PDF] Optimizing Of The High-Throughput DNA Repair Assay For Immunotherapy
J Carter, G Peng, X Cheng - 2023 - openworks.mdanderson.org
Results Fanconi anemia (FA), breast, and ovarian cancers are predisposed to by mutations
in the BRCA2 (BReast CAncer gene 2) recombination gene. Homologous recombination …
in the BRCA2 (BReast CAncer gene 2) recombination gene. Homologous recombination …